Professional Documents
Culture Documents
BY :
NSUBUGA IVAN
NANDELENGA MERCY
MWALIM MARYM OMAR
MUGISHA RUTH
SUPERVISED BY :
DR LAGORO CHARLES, CONSULTANT INTERNAL MEDICINE (M.MED)
Thyroid Gland
• two lobed mass in the anterior neck btn cricoid cartilage and suprasternal notch
MANAGEMENT-
• oral/iv thyroxine(iv levothyroxine single bolus 200-400ug loading dose, daily oral
dose of 1.6ug/kg/d-reduced by 25% if given iv) gradually increase dose,
rewarming(only if temp<30ºC), rehydration, hydrocortisone iv 50mg 6hrly,
liothyronine iv/oral (intial dose 5-20ug then 2.5-10ug 8hrly, lower dose for those
at CVS risk-arrhythmias)
HYPERTHYROIDISM
Defn: hyperthyroidism is a state of excessive thyroid function while
hyrotoxicosis is a state of thyroid hormone excess
• Common- 2-5% all females.
• M:F= 1:5
• Thyroid acropachy
• Pretibial myxoedema
• Serum TSH-
• Radio iodine
• Surgery
ANTITHYROID DRUGS
• Carbimazole / Methimazole (10-20mg 8hrly/12hrly)
• Rash, nausea and vomiting, agranulocytosis(0.1%), jaundice
• Both inhibit formation of thyroid hormones
• CBZ- has mild immunosupressive action
• Propythiouracil(100-200mg 6-8hrly)
• Rash, N+V, aplastic anaemia
• PTU- inhibits peripheral conversion of T4-T3
• Gradually reduce dose after 6-12 months once TSH normal
• 50% will relapse over next 2 years
AGRANULOCYTOSIS
•Risk of 1 in 1000
• Moderate
• steroids
• Severe
• Irradiation of the orbits
• Lateral tarsorraphy
• Surgical decompression
THE END
Reference
Harrison textbook of internal medicine 20th edition